Literature DB >> 17018303

Clarifying margins in the multidisciplinary management of rectal cancer: the MERCURY experience.

G Salerno1, I R Daniels, B J Moran, A Wotherspoon, G Brown.   

Abstract

The Magnetic Resonance Imaging and Rectal Cancer European Equivalence Study (MERCURY) was an observational prospective study involving 11 European centres, to evaluate equivalence between magnetic resonance imaging and histopathology in measuring depth of tumour invasion beyond the bowel and involvement of the circumferential resection margin in rectal cancer specimens.

Entities:  

Mesh：

Year:  2006        PMID： 17018303     DOI： 10.1016/j.crad.2006.06.005

Source DB:  PubMed          Journal:  Clin Radiol        ISSN： 0009-9260            Impact factor:   2.350


  15 in total

Review 1.  Update on the surgical pathology standards on rectal cancer diagnosis, staging and quality assessment of surgery.

Authors:  Alejandro Rojo; Pilar Sancho; Oscar Alonso; Sara Encinas; Gemma Toledo; Juan F García
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

Review 2.  How Should Imaging Direct/Orient Management of Rectal Cancer?

Authors:  Jemma Bhoday; Svetlana Balyasnikova; Anita Wale; Gina Brown
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

3.  Enterocutaneous fistula associated with malignancy and prior radiation therapy.

Authors:  Luiz Felipe de Campos-Lobato; Jon D Vogel
Journal:  Clin Colon Rectal Surg       Date:  2010-09

Review 4.  Low anterior resection syndrome (LARS): cause and effect and reconstructive considerations.

Authors:  Y Ziv; A Zbar; Y Bar-Shavit; I Igov
Journal:  Tech Coloproctol       Date:  2012-10-18       Impact factor: 3.781

5.  Current trends in staging rectal cancer.

Authors:  Abdus Samee; Chelliah Ramachandran Selvasekar
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

Review 6.  The role of the pathologist in rectal cancer diagnosis and staging and surgical quality assessment.

Authors:  Carmen Faus; Desamparados Roda; Matteo Frasson; Susana Roselló; Eduardo García-Granero; Blas Flor-Lorente; Samuel Navarro
Journal:  Clin Transl Oncol       Date:  2010-05       Impact factor: 3.405

7.  MRI can be used to assess advanced T-stage colon carcinoma as well as rectal carcinoma.

Authors:  Akitoshi Inoue; Shinichi Ohta; Norihisa Nitta; Masahiro Yoshimura; Tomoharu Shimizu; Masaji Tani; Ryoji Kushima; Kiyoshi Murata
Journal:  Jpn J Radiol       Date:  2016-10-18       Impact factor: 2.374

Review 8.  Proforma-based reporting in rectal cancer.

Authors:  F Taylor; N Mangat; I R Swift; G Brown
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

9.  Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients.

Authors:  Lisardo Ugidos; Salvadora Delgado; Carlos Conill; Angels Ginés; Rosa Gallego; Juan Ramón Ayuso; Rosa Miquel; Monica Tosca; Antonio de Lacy; Antoni Castells; Joan Maurel
Journal:  Invest New Drugs       Date:  2008-10-16       Impact factor: 3.850

Review 10.  Current options for the management of rectal cancer.

Authors:  Bert H O'Neil; Joel E Tepper
Journal:  Curr Treat Options Oncol       Date:  2007-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.